New therapy boosts resilience for mental health caregivers
NCT ID NCT07643714
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a program based on Acceptance and Commitment Therapy (ACT) for 64 caregivers of people with mental disorders. The program aimed to help caregivers build psychological resilience, manage stress better, and feel less burdened. Results showed that those who took part in the program improved compared to those who did not.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
64 people
The number who actually took part.
- Started
-
Oct 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Aged 18 years or older Being a first-degree caregiver of an individual with severe mental disorder followed at a CMHC or outpatient clinic Turkish-speaking and at least primary school graduate No communication problems and open to cooperation Not having participated in any ACT-based or similar psychoeducation program in the last 6 months No alcohol/substance use disorder No psychiatric diagnosis Having regularly attended the intervention sessions - Exclusion Criteria:Not meeting the inclusion criteria \-
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Caregiver burden are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kahramanmaras Necip Fazil City Hospital, Psychiatry Outpatient Clinic and Community Mental Health Center
Kahramanmaraş, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug
- A shot every few weeks? new drug tested for schizophrenia